TeneoBio
Newark · Founded 2009
About TeneoBio
TeneoBio is a biotechnology company that specializes in the development of human heavy chain antibodies. It has several products in pre-clinical and clinical development for the treatment of multiple myeloma, prostate cancer, and immune disorders. TeneoBio’s antibody discovery engine is based on UniRat™, a proprietary heavy chain only, human immunoglobulin transgenic rat.
Company Facts
- Founded: 2009
- Legal name: TeneoBio, Inc.
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Funding stage: M&A
- Last round: Series Unknown (Oct 2018)
- Website: teneobio.com
- Phone: 650-899-8200
Social Profiles
Canonical: https://fsome.com/organization/teneobio-8350383 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.